{"id":"https://genegraph.clinicalgenome.org/r/51cdf895-94c1-418f-a0fc-bcd0f30a7bd8v1.1","type":"EvidenceStrengthAssertion","dc:description":"*TRPM1* was first reported in relation to autosomal recessive cases of congenital stationary night blindness type 1C by three groups in 2009 (PMIDs: 19878917, 19896109, 19896113). The hallmark CSNB phenotype is night blindness from birth or early childhood with a severely reduced or completely absent scotopic b-wave in an ERG, but normal or mildly affected a-wave. Patients also commonly present with myopia, nystagmus and/or strabismus. Because of the broad spectrum of potential phenotypes, these cases with causal variants in *TRPM1* have been curated under the inclusive disease name *TRPM1*-related retinopathy (MONDO:0800402).\n \nTwelve variants (four nonsense, three missense, two frameshift, and three intronic) that have been reported in eight probands in five publications (PMIDs: 35633130, 19896113, 20300565, 19896109, 19878917) are included in this curation. The mechanism of pathogenicity appears to be biallelic loss-of-function.\n\nThis gene-disease association is also supported by experimental evidence that *TRPM1* exhibits its highest expression levels in retina tissue (PMID: 19878917). Additionally, expression of TRPM1 in the retina of horses with a CSNB phenotype is 0.05% of the level found in horses with normal vision (PMID: 18660533). Immunolocalization shows that TRPM1 is localized to ON bipolar cell dendrites in the outer plexiform layer (OPL) of the retina (PMID: 19896109). The ERG b-wave is absent (a defining phenotype of CSNB) in a *Trpm1 (-/-)* knockout mouse (PMID: 20300565). These ERG results have been replicated in another *Trpm1* null mutant mouse experiment (PMID: 19861548). Furthermore, this group has also found that TRPM1 immuno-staining is absent in the OPL layer of retinal cells in *Trpm1(−/−)* mice. They go on to show that OKR response is reduced in knockout mice. Finally, these authors show that cell response is absent (in rod cells) or highly altered (in cone cells) in *Trpm1 (-/-)* mice (PMID: 19861548).\n\nIn summary, *TRPM1* is definitively associated with autosomal recessive inheritance of *TRPM1*-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification according to the ClinGen template. This classification was approved by the ClinGen Retina GCEP on October 6, 2022 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/51cdf895-94c1-418f-a0fc-bcd0f30a7bd8","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-10-06T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2023-07-03T18:56:03.244Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/090c6532-82b3-4588-ad0e-f66555e5f931_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/090c6532-82b3-4588-ad0e-f66555e5f931","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20300565","rdfs:label":"Nakamura_#437","allele":[{"id":"https://genegraph.clinicalgenome.org/r/69590343-2a14-45f7-9bba-6fe060ae9d6c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.1936C>T (p.Arg646Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129158"}},{"id":"https://genegraph.clinicalgenome.org/r/7d1ef972-d954-4e02-b467-9cb2eb56d217","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.2711C>A (p.Ser904Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213022"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"myopic, ERG concistent with cCSNB","previousTesting":true,"previousTestingDescription":"Screened for GRM6 and NYX mutations","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/894adc88-4864-4be6-a3de-4d2e0c4b7053_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20300565","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d1ef972-d954-4e02-b467-9cb2eb56d217"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/25c3ce12-2999-4281-9297-7128435c79d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20300565","allele":{"id":"https://genegraph.clinicalgenome.org/r/69590343-2a14-45f7-9bba-6fe060ae9d6c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/25c3ce12-2999-4281-9297-7128435c79d9","type":"EvidenceLine","dc:description":"\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25c3ce12-2999-4281-9297-7128435c79d9_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/894adc88-4864-4be6-a3de-4d2e0c4b7053","type":"EvidenceLine","dc:description":"WES not used for genotyping. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/894adc88-4864-4be6-a3de-4d2e0c4b7053_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/da62ae6a-ef05-4b23-a2c8-7d6d59c4983f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da62ae6a-ef05-4b23-a2c8-7d6d59c4983f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896113","rdfs:label":"Audo_4497","allele":[{"id":"https://genegraph.clinicalgenome.org/r/be3ce75b-2cf9-4108-95b7-6c0a047fd42c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.97C>T (p.Gln33Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA118067"}},{"id":"https://genegraph.clinicalgenome.org/r/78765bd3-163c-4007-bb64-eff38f2e9b1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.362T>C (p.Leu121Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA118069"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"cCSNB, nystagmus, myopia","previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f172b235-65e5-4b15-a403-9a656ebe49f7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896113","allele":{"id":"https://genegraph.clinicalgenome.org/r/78765bd3-163c-4007-bb64-eff38f2e9b1a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/59a4c075-0b2d-4157-af5f-dc3c7f0b48bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896113","allele":{"id":"https://genegraph.clinicalgenome.org/r/be3ce75b-2cf9-4108-95b7-6c0a047fd42c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/59a4c075-0b2d-4157-af5f-dc3c7f0b48bc","type":"EvidenceLine","dc:description":"WES not used for genotyping (-0.5)\nNo previous testing (-0.5)\n\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59a4c075-0b2d-4157-af5f-dc3c7f0b48bc_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f172b235-65e5-4b15-a403-9a656ebe49f7","type":"EvidenceLine","dc:description":"CA118069 variant in case # 4497 is present in the European (non-Finnish) population at a frequency of 0.0002564 (33/128694 alleles). Should it still be scored? ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f172b235-65e5-4b15-a403-9a656ebe49f7_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/b73ee2eb-88a6-462c-8206-ea3f8f4a2a0a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b73ee2eb-88a6-462c-8206-ea3f8f4a2a0a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896109","rdfs:label":"vanGenderen_Proband2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a537b6bf-18ae-4397-84a7-f3de1d006443","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.149del (p.Asn50MetfsTer62)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320497"}},{"id":"https://genegraph.clinicalgenome.org/r/9b77a961-92d5-4646-891a-31cc136b4bf8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.1666G>A (p.Gly556Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7452473"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"ERG consistent with cCSNB, absent rod adaption in Goldman‐Weekers dark adaptometery test","previousTesting":true,"previousTestingDescription":"Screened for GRM6 and NYX","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/39038288-b306-4732-90cd-dd8146399927_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896109","allele":{"id":"https://genegraph.clinicalgenome.org/r/a537b6bf-18ae-4397-84a7-f3de1d006443"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/0194d03a-1e5b-44eb-9c85-522b58ef4896_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896109","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b77a961-92d5-4646-891a-31cc136b4bf8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/39038288-b306-4732-90cd-dd8146399927","type":"EvidenceLine","dc:description":"WES not performed for genotyping (-0.5)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39038288-b306-4732-90cd-dd8146399927_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0194d03a-1e5b-44eb-9c85-522b58ef4896","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0194d03a-1e5b-44eb-9c85-522b58ef4896_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/0d509eb8-b2ff-493c-9ea4-a0ba025bb47e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d509eb8-b2ff-493c-9ea4-a0ba025bb47e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896113","rdfs:label":"Audo_691","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab3552ce-2bd2-4b42-a774-65a39ee299a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.2633G>A (p.Trp878Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7452120"}},"firstTestingMethod":"Sanger sequencing","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/219ffe8e-a201-45ec-b297-a9ca62a21210_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896113","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab3552ce-2bd2-4b42-a774-65a39ee299a9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/219ffe8e-a201-45ec-b297-a9ca62a21210","type":"EvidenceLine","dc:description":"Homozygous default = 2 pts\nNo WES = -0.5\nNo previous testing = -0.5\n1 point total","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/219ffe8e-a201-45ec-b297-a9ca62a21210_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c4a68923-7eb0-4035-981e-47f36826c7b4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4a68923-7eb0-4035-981e-47f36826c7b4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878917","rdfs:label":"Li_Family2_Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/605a2b8c-8387-49a7-8003-862d13f9293e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.3171T>A (p.Tyr1057Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA118065"}},{"id":"https://genegraph.clinicalgenome.org/r/2a8f8b2a-3a5f-4d55-a0a8-3cc3eac12c35","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.482del (p.Gly161fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1459633"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"nystagmus, CSNB, myopic , right convergent squint, ERG was typical of cCSNB. ","previousTesting":true,"previousTestingDescription":"Additional patients and families with a phenotype consistent with cCSNB, attending the retinal clinics at Moorfields Eye Hospital, were screened for mutations in GRM6 and, if male, NYX. We purposefully biased the cohort toward female patients and siblings, to enrich it for autosomal genes. Of 12 families screened for GRM6 mutations, three were found to have mutations. Only one family was consistent with X-linked segregation, and was therefore screened for NYX, which also showed no mutations. The nine familes that were negative were screened for mutations in TRPM1.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7027ad8c-e936-4618-b1af-4ecd9d65c988_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878917","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a8f8b2a-3a5f-4d55-a0a8-3cc3eac12c35"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2d9d5e73-5a37-429f-aee5-457acb2484eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878917","allele":{"id":"https://genegraph.clinicalgenome.org/r/605a2b8c-8387-49a7-8003-862d13f9293e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/2d9d5e73-5a37-429f-aee5-457acb2484eb","type":"EvidenceLine","dc:description":"WES not used for genotyping. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d9d5e73-5a37-429f-aee5-457acb2484eb_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7027ad8c-e936-4618-b1af-4ecd9d65c988","type":"EvidenceLine","dc:description":"WES not used for genotyping. Confirmed in trans. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7027ad8c-e936-4618-b1af-4ecd9d65c988_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/994d0c23-1f82-4cac-8d05-79cc1d173df1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/994d0c23-1f82-4cac-8d05-79cc1d173df1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35633130","rdfs:label":"Iosifidis_Case3","allele":{"id":"https://genegraph.clinicalgenome.org/r/039695a9-3488-4f64-9268-ef454a26c059","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.31063089C>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7452748"}},"detectionMethod":"Briefly, DNA samples were processed using Agilent SureSelect target enrichment kits (Agilent Technologies, Santa, Clara, CA) designed to capture all exons and 50 base-pairs of flanking intronic sequences of 176 genes associated with inherited retinal disorders. Sequencing was then performed using a NextSeq500 (Illumina, San Diego, CA) p, according to the manufacturer's protocols","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"High myopia; nyctalopia; strabismus","previousTesting":true,"previousTestingDescription":"Briefly, DNA samples were processed using Agilent SureSelect target enrichment kits (Agilent Technologies, Santa, Clara, CA) designed to capture all exons and 50 base-pairs of flanking intronic sequences of 176 genes associated with inherited retinal disorders. Sequencing was then performed using a NextSeq500 (Illumina, San Diego, CA) p, according to the manufacturer's protocols","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/10b7e9c7-e699-406c-a0be-9c2c845faa69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35633130","allele":{"id":"https://genegraph.clinicalgenome.org/r/039695a9-3488-4f64-9268-ef454a26c059"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/10b7e9c7-e699-406c-a0be-9c2c845faa69","type":"EvidenceLine","dc:description":"Downgraded for consanguinity","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10b7e9c7-e699-406c-a0be-9c2c845faa69_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/10b7e9c7-e699-406c-a0be-9c2c845faa69_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Another study participant (case 3) was found to be homozygous for an intronic TRPM1 variant, c.965 + 29G>A, which was predicted to be disruptive by the SpliceAI tool (scoring 0.5 against a pre-defined threshold of 0.5) (Jaganathan et al. 2019). A mini-gene assay highlighted that this change affects normal splicing, causing inclusion of 30 nucleotides of TRPM1 intron 9 (r.899_900ins899 + 1_899 + 30) and resulting in the introduction of a premature stop codon p.(Ile323Ter) (Rowlands et al. 2021).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/61756319-ff92-44a3-a10e-febad1c6a338_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61756319-ff92-44a3-a10e-febad1c6a338","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20300565","rdfs:label":"Nakamura_484","allele":[{"id":"https://genegraph.clinicalgenome.org/r/69590343-2a14-45f7-9bba-6fe060ae9d6c"},{"id":"https://genegraph.clinicalgenome.org/r/9f4ccd2b-90c9-48af-824e-8faf640aa87b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.1089+3_1089+6del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213024"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"myopic, ERG consistent with cCSNB\n","previousTesting":true,"previousTestingDescription":"Screened for GRM6 and NYX mutations\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2113b5e0-0aeb-4f24-8b58-98ea5abd055d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20300565","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f4ccd2b-90c9-48af-824e-8faf640aa87b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/82e259ea-12e5-4ee7-b15f-eb3ad5dc6e06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20300565","allele":{"id":"https://genegraph.clinicalgenome.org/r/69590343-2a14-45f7-9bba-6fe060ae9d6c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/2113b5e0-0aeb-4f24-8b58-98ea5abd055d","type":"EvidenceLine","dc:description":"Null variant = 1.5 pts\nWith functional evidence = + 0.4 pts\nNo WES genotyping performed = - 0.5 pts\nTotal score = 1.4 pts, rounded up to 1.5 pts\n\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2113b5e0-0aeb-4f24-8b58-98ea5abd055d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2113b5e0-0aeb-4f24-8b58-98ea5abd055d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The authors generated mutated minigenes containing the IVS8+3_6delAAGT mutation and transfected into HEK293T cells. WT minigenes produced a 39 kDa band but the IVS8+3_6delAAGT containing cells produced no visible band (Figure 2C). \n\nAdditionally, the IVS8+3_6delAAGT mutation was also predicted to affect RNA splicing, as assessed by an online splice-site prediction tool. The donor site prediction score from the software for the exon 8 donor site in TRPM1 was 0.99 for the WT sequence, whereas it was under 0.01 for the corresponding mutated sequence with the IVS8+3_6delAAGT sequence change.\n\nThese results showed that the IVS8+3_6delAAGT mutations abrogate normal splicing and lead to abnormal protein production, suggesting that this trpm1 allele is a loss-of-function allele.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/82e259ea-12e5-4ee7-b15f-eb3ad5dc6e06","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82e259ea-12e5-4ee7-b15f-eb3ad5dc6e06_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/60d7de6c-c83b-4978-a0d2-05e651ef7cf1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60d7de6c-c83b-4978-a0d2-05e651ef7cf1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878917","rdfs:label":"Li_Family1_Mother","allele":{"id":"https://genegraph.clinicalgenome.org/r/899fee71-df9d-4980-b7d8-ab4647d0fc54","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001252024.2(TRPM1):c.2087+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6223"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"nonprogressive nyctalopia, convergent squint, bilateral high myopia, myopic fundi, ERG consistent with cCSNB","previousTesting":true,"previousTestingDescription":"Additional patients and families with a phenotype consistent with cCSNB, attending the retinal clinics at Moorfields Eye Hospital, were screened for mutations in GRM6 and, if male, NYX. We purposefully biased the cohort toward female patients and siblings, to enrich it for autosomal genes. Of 12 families screened for GRM6 mutations, three were found to have mutations. Only one family was consistent with X-linked segregation, and was therefore screened for NYX, which also showed no mutations. The nine familes that were negative were screened for mutations in TRPM1. ","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/37687dcd-f563-4197-ad11-154a2820d866_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878917","allele":{"id":"https://genegraph.clinicalgenome.org/r/899fee71-df9d-4980-b7d8-ab4647d0fc54"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/37687dcd-f563-4197-ad11-154a2820d866","type":"EvidenceLine","dc:description":"Homozygous default = 2 pts\nWES not included for genotyping (-0.5 pts)\nLack of functional evidence to support mis-splicing assertion\n1.5 pts TOTAL","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37687dcd-f563-4197-ad11-154a2820d866_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.9},{"id":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4db73c99-8ade-4d3b-a967-52ee4e7b158b","type":"EvidenceLine","dc:description":"Increased score because of the specificity of the expression of TRPM1 in the retina according to the eyeIntegration database. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/856ce2ab-6ddc-43c1-aa4a-8d1955655120","type":"Finding","dc:description":"Using human retina RNA, the experiment used RT-PCR to amplify a variety of TRPM1 transcripts. The eyeIntegration database supports the high levels of TRPM1 expression in the retina. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878917","rdfs:label":"Li_RT-PCR","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/613713ab-0afe-4fbe-be77-97e23150bc50","type":"EvidenceLine","dc:description":"Experiment was done in a non-traditional model system, however, there is a large fold-change in expression between affected and unaffected \"patients\". Scored at default points. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/958faa38-a510-407b-b7a0-459264a5de3e","type":"Finding","dc:description":"- Used LP genotype (directly associated with CSNB, inferred by coat pattern) and CSNB diagnosis (categorized by ocular examination, which included. neurophthalmic examination, slit-lamp biomicroscopy, indirect ophthalmoscopy, and electroretinography) to confirm CSNB in appaloosa horses. Horses were included in the LP/LP group if they had a “fewspot” or “snowcap blanket” pattern and a scotopic ERG consistent with CSNB”\n\n- Horses in the LP/lp group all displayed white patterning with dark spots and/or had breeding records consistent with heterozygosity (“leopard,” “spotted blanket,” or “lace blanket” patterns) and a normal scotopic ERG. Horses were included in the non-appaloosa (lp/lp) group if they were solid colored and showed no other traits associated with the presence of LP (striped hooves, white sclera, and mottled skin) and a normal scotopic ERG\n\n- Found that TRPM1 from retina total RNA was differentially expressed between LP/LP (CSNB) horses and LP/lp and lp/lp (expression in LP/LP was 0.05% of the level found in non-appaloosa horses)\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18660533","rdfs:label":"Bellone_DifferentialExpression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/34935f9d-a6e9-4cea-afcc-dcd72e8a2827","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/589b2bf8-17eb-408a-855e-f2295e297073","type":"Finding","dc:description":"Figure 1 shows that TRPM1 is localized to the ON bipolar cell dendrites in the outer plexiform layer (OPL) of the retina. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19896109","rdfs:label":"van_Genderen_Immunolocalization","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5ecc95d2-f47b-4238-9475-2bd96f4b92db_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/995d5505-58b9-400f-b0a3-21e7c96d3a1f","type":"EvidenceLine","dc:description":"Due to the extensive work that Morgans et al. did in their TRPM1 null mouse model, I scored it at 2 points. Because of the similar ERG result found by PMID: 20300565 in their TRPM1 knockout mouse model, I upgraded the Morgans model to 3 points total. Additionally, the Morgans mouse model recapitulates many of the primary CSNB phenotypes seen in human patients. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34c8efe4-355f-42bd-899a-f739456a751c","type":"Finding","dc:description":"The ERG trace of the knockout mice is representative of the results seen in humans with cCSNB","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19861548","rdfs:label":"Morgans_MouseModel","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":6597,"specifiedBy":"GeneValidityCriteria9","strengthScore":15.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/weXVseMmGas","type":"GeneValidityProposition","disease":"obo:MONDO_0800402","gene":"hgnc:7146","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5ecc95d2-f47b-4238-9475-2bd96f4b92db-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}